Rising Hemorrhages Drive Neurovascular Embolization Devices Market Growth: Transformative Forces Shaping the Neurovascular Embolization Devices Market Landscape in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Neurovascular Embolization Devices Industry Market Size Be by 2025?
In the past few years, the neurovascular embolization devices market size has experienced consistent growth. Its value is predicted to increase from $1.32 billion in 2024 to $1.38 billion in 2025, yielding a compound annual growth rate (CAGR) of 4.8%. The growth observed in the past years is credited to a higher occurrence of neurovascular maladies, a surge in the elderly population, a growing preference for less invasive procedures, enhancements in healthcare infrastructure, and a rise in healthcare spending.

What's the Long-Term Growth Forecast for the Neurovascular Embolization Devices Market Size Through 2029?
Anticipated to experience robust growth in the near future, the neurovascular embolization devices market is predicted to reach a value of $1.78 billion in 2029, growing at a compound annual growth rate (CAGR) of 6.5%. This growth in the forecasted timeline is likely due to the widening applications in emerging markets, an increased focus on patient-driven care, greater understanding of neurovascular conditions, improved imaging technologies, and larger investments in research and development. Key trend forecasts include bespoke treatment methods, incorporation of AI in treatment strategy, the introduction of advanced embolic materials, a shift towards outpatient and ambulatory procedures and the development of novel embolization techniques.

View the full report here:
https://www.thebusinessresearchcompany.com/report/neurovascular-embolization-devices-global-market-report

What Are the Key Growth Drivers Fueling the Neurovascular Embolization Devices Market Expansion?
The neurovascular embolization devices market is anticipated to grow, propelled by an increase in hemorrhages. Hemorrhages, which are irregular, unchecked bleeding that can take place internally in the body or externally through skin or mucous membrane breaks, have several causes. These include aging populations, higher incidence of hypertension, and more extensive use of anticoagulant drugs. Neurovascular embolization devices play a critical role in managing hemorrhagic strokes by blocking abnormal blood vessels, minimizing bleeding, and averting additional brain damage. As an example, research from King's College London, a UK-based public research university, predicted in February 2024 that the number of cases and deaths due to intracerebral hemorrhage (a specific type of hemorrhage) amongst individuals aged 70 to 95 in the UK would rise by 59.4% by 2050. This rise in hemorrhages prevalence thus fuels the neurovascular embolization devices market's expansion.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15871&type=smp

What Long-Term Trends Will Define the Future of the Neurovascular Embolization Devices Market?
Major corporations involved in the neurovascular embolization devices sector are concentrating on creating goods equipped with cutting-edge technology such as shield technology. This approach is targeted towards treating brain aneurysms effectively and giving them a competitive advantage in the marketplace. Shield technology signifies a high-tech feature designed to boost the performance and safety of the devices, in turn, increasing the durability and longevity of embolization devices. For instance, in June 2022, Medtronic PLC, a health technology firm based in Ireland, introduced a fourth-generation flow diverter named Pipeline Vantage equipped with Shield Technology in India. The advanced design features aim to enhance the device's usability and dependability during endovascular operations. The device promotes cellular development in the blood vessel's inner lining, providing a framework that assists in the non-invasive treatment of aneurysms, decreases rupture risk, and enhances patient's health outcomes.

How Is the Neurovascular Embolization Devices Market Segmented?
The neurovascular embolization devices market covered in this report is segmented -

1) By Product: Embolization Coils, Liquid Embolic Systems, Flow Diversion Stents, Aneurysm Clips, Other Products
2) By Treatment: Ischemic Stroke Solution, Hemorrhagic Stroke Solutions
3) By Indication: Brain Aneurysms, Arteriovenous Malformation, Other Indications
4) By End User: Hospitals, Ambulatory Surgical Centers, Other End Users

Subsegments:
1) By Embolization Coils: Detachable Coils, Bare Platinum Coils, Coils With Hydrogel Coatings
2) By Liquid Embolic Systems: Gluteraldehyde-Based Liquid Embolization, Onyx Liquid Embolic System
3) By Flow Diversion Stents: Stents With Dual-Layer Technology, Flow Diverters For Aneurysm Treatment
4) By Aneurysm Clips: Titanium Clips, Stainless Steel Clips
5) By Other Products: Balloons For Embolization, Microcatheters

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=15871&type=smp

Which Companies Are Leading the Charge in Neurovascular Embolization Devices Market Innovation?
Major companies operating in the neurovascular embolization devices market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, Heraeus Holding, Stryker Corporation, Boston Scientific Corporation, Kaneka Corporation, Terumo Corporation, B Braun Melsungen AG, Cook Medical LLC, Integer Holdings Corporation, Merit Medical Systems Inc., Penumbra Inc., Asahi Intecc Co Ltd., MicroVention Inc., Balt USA LLC, Imperative Care Inc., InNeuroCo Inc., Acandis GmbH & Co KG, Rapid Medical Ltd., Emboline Inc., InspireMD Inc., QXMedical LLC, Vesalio LLC, EmbolX Inc

Which Regions Are Leading the Global Neurovascular Embolization Devices Market in Revenue?
North America was the largest region in the neurovascular embolization devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neurovascular embolization devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15871

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.